GLP-1 receptor agonist

The cost of Wegovy will soon be covered by Medicare, according to an announcement from the federal health insurance program for seniors on Thursday. And while that’s great news for people over 65 who want access to a medication that’s drawn so much attention for its ability to help with weight loss, there’s just one catch. Medicare will only pay if patients have potentially serious heart problems.The Fujifilm X100VI is the Most Fun I’ve Had With a Camera in YearsWegovy is the brand name of Novo Nordisk’s anti-obesity…

Pharmaceutical company Eli Lilly is making a plea to some of its customers: stop hoarding our weight loss drugs. In a new Oscar-themed commercial set to run on TV this weekend, the drugmaker is not-so-subtly telling people to stay away from its new blockbuster medications if they’re only looking to lose a few pounds. These and similar drugs have continuously experienced shortages since their debut in recent years, with demand far outstripping supply.An AI That Helps You Get a Job? | AI UnlockedThe 30-second reverse…

Another week, another study finding that Ozempic/Wegovy and similar drugs may do a lot more than just help people lose weight. New research has found that patients who start taking GLP-1 drugs are less likely to be diagnosed with depression and anxiety afterward, compared to similar patients not on the drug. The findings do not prove a cause-and-effect relationship, but provide further evidence that these drugs are not typically harmful to people’s mental health.The Animal Kingdom Imagines a World of Humans Turning Into…

A popular class of weight loss and diabetes drugs looks to be safer than feared, at least so far. This week, the Food and Drug Administration announced it hasn’t found compelling evidence that Wegovy, Ozempic, and other GLP-1 drugs can cause suicidal thoughts or behaviors—a concern that first emerged last year. The FDA hasn’t definitively ruled out a possible connection just yet, however, and it is still conducting further investigation into the matter.Would Peter Capaldi Return to Doctor Who?In summer 2023, health…

Wegovy and similar weight loss drugs may cause more side effects than currently recognized. The Food and Drug Administration is now looking into whether these new generation obesity drugs can trigger hair loss, suicide ideation, and food aspiration, based on adverse event reports linked to their use. These reports are only intended to be a potential warning signal and do not prove causation, but the FDA could take further regulatory action should their investigation bear fruit, such as modifying the drugs’ labeling.Let’s…